Analyst Consensus ?
ConsensusBuy39 ratings
Bullish2153.8%
Neutral1743.6%
Bearish12.6%
FN2 Earnings Intelligence
DuPont de Nemours, Inc. (DD) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Oct 15, 2026 |
| JP Morgan | Neutral | Overweight | Downgrade | Oct 9, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 7, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 23, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 21, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Feb 18, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 12, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 11, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Feb 11, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 11, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Dec 18, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 29, 2025 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 9, 2022 |
| Vertical Research | Buy | Hold | Upgrade | Nov 3, 2021 |
| Argus Research | Buy | Buy | Maintain | May 14, 2021 |
| Goldman Sachs | Buy | Neutral | Upgrade | May 11, 2021 |
| DZ Bank | Hold | Sell | Upgrade | Feb 11, 2021 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Jan 28, 2021 |
| Susquehanna | Neutral | Positive | Downgrade | Jan 27, 2021 |
| HSBC | Hold | Buy | Downgrade | Jan 13, 2021 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Aug 3, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 6, 2020 |
| CFRA | Buy | Buy | Maintain | May 5, 2020 |
| Gordon Haskett | Buy | Buy | Maintain | Jan 14, 2020 |
| Bank of America | Buy | Buy | Maintain | Nov 11, 2019 |
| Citi | Buy | Buy | Maintain | Aug 2, 2019 |
| Nomura | Neutral | Neutral | Maintain | Jun 13, 2019 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jun 10, 2019 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Bernstein | Outperform | Outperform | Maintain | Sep 1, 2017 |
| CLSA | Underperform | Outperform | Downgrade | Apr 27, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Jul 29, 2015 |
| BGC Financial | Buy | Hold | Upgrade | Sep 19, 2014 |
| PiperJaffray | Neutral | Neutral | Maintain | Jun 5, 2013 |
| Piper Sandler | Neutral | Neutral | Maintain | Jun 5, 2013 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Oct 24, 2012 |
| Monness Crespi Hardt | Neutral | Buy | Downgrade | Oct 24, 2012 |
| S&P Capital IQ | Buy | Hold | Upgrade | Jul 24, 2012 |
Upside is calculated against the persisted current price $140.58. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Arun Viswanathan | $160 | $129.92 | +13.8% | Oct 15, 2026 |
| Barclays | Aleksey Yefremov | $156 | $129.37 | +11.0% | Oct 12, 2026 |
| UBS | Analyst unavailable | $172 | $129.98 | +22.4% | Oct 5, 2026 |
| UBS | Analyst unavailable | $178 | $145.59 | +26.6% | Aug 5, 2026 |
| Goldman Sachs | Joe Ritchie | $53 | $48.26 | -62.3% | Jun 15, 2026 |
| RBC Capital | Analyst unavailable | $60 | $50.54 | -57.3% | May 11, 2026 |
| UBS | Analyst unavailable | $59 | $49.69 | -58.0% | May 6, 2026 |
| RBC Capital | Analyst unavailable | $56 | $46.06 | -60.2% | Apr 24, 2026 |
| Deutsche Bank | Analyst unavailable | $58 | $50.87 | -58.7% | Feb 18, 2026 |
| BMO Capital | Analyst unavailable | $60 | $52.31 | -57.3% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $52 | $51.47 | -63.0% | Feb 11, 2026 |
| UBS | Analyst unavailable | $56 | $50.32 | -60.2% | Feb 11, 2026 |
| RBC Capital | Arun Viswanathan | $161 | $50.35 | +14.5% | Feb 11, 2026 |
| Mizuho Securities | Analyst unavailable | $52 | $49.43 | -63.0% | Feb 11, 2026 |
| KeyBanc | Aleksey Yefremov | $57 | $50.75 | -59.5% | Feb 11, 2026 |
| Deutsche Bank | David Begleiter | $46 | $43.88 | -67.3% | Jan 23, 2026 |
| RBC Capital | Analyst unavailable | $51 | $43.11 | -63.7% | Jan 21, 2026 |
| KeyBanc | Aleksey Yefremov | $51 | $43.4 | -63.7% | Jan 9, 2026 |
| UBS | Joshua Spector | $49 | $42.89 | -65.1% | Jan 7, 2026 |
| Mizuho Securities | Analyst unavailable | $46 | $40.61 | -67.3% | Dec 18, 2025 |
| RBC Capital | Arun Viswanathan | $48 | $38.7 | -65.9% | Nov 18, 2025 |
| Morgan Stanley | Analyst unavailable | $44 | $40.14 | -68.7% | Nov 10, 2025 |
| KeyBanc | Aleksey Yefremov | $45 | $39.69 | -68.0% | Nov 7, 2025 |
| UBS | Joshua Spector | $44 | $39.13 | -68.7% | Nov 5, 2025 |
| BMO Capital | John McNulty | $50 | $34.38 | -64.4% | Nov 3, 2025 |
| Mizuho Securities | Analyst unavailable | $37.66 | $31.71 | -73.2% | Sep 2, 2025 |
| BMO Capital | John McNulty | $44.77 | $32.18 | -68.2% | Aug 29, 2025 |
| New Street | Analyst unavailable | $44.77 | $32.18 | -68.2% | Aug 29, 2025 |
| UBS | Joshua Spector | $36.4 | $31.29 | -74.1% | Jul 9, 2025 |
| UBS | Joshua Spector | $35.56 | $28.41 | -74.7% | May 21, 2025 |
| RBC Capital | Arun Viswanathan | $37.66 | $27.64 | -73.2% | Apr 24, 2025 |
| RBC Capital | Arun Viswanathan | $42.68 | $32.57 | -69.6% | Aug 5, 2024 |
| BMO Capital | John McNulty | $41.84 | $34.64 | -70.2% | Aug 1, 2024 |
| Wells Fargo | Michael Sison | $43.93 | $35.02 | -68.7% | Aug 1, 2024 |
| Barclays | Duffy Fischer | $35.56 | $33.94 | -74.7% | May 28, 2024 |
| Wells Fargo | Michael Sison | $43.1 | $33.03 | -69.3% | May 24, 2024 |
| BMO Capital | John McNulty | $40.17 | $33.09 | -71.4% | May 23, 2024 |
| Mizuho Securities | John Roberts | $41.84 | $33.17 | -70.2% | May 23, 2024 |
| Jefferies | Laurence Alexander | $42.26 | $32.46 | -69.9% | May 17, 2024 |
| RBC Capital | Arun Viswanathan | $36.4 | $32.53 | -74.1% | May 3, 2024 |
| Bank of America Securities | Steve Byrne | $33.47 | $30.85 | -76.2% | Jan 16, 2024 |
| Citigroup | Analyst unavailable | $37.24 | $32.27 | -73.5% | Feb 8, 2023 |
| Wells Fargo | Analyst unavailable | $35.56 | $32.25 | -74.7% | Feb 8, 2023 |
| Barclays | Analyst unavailable | $33.47 | $32.55 | -76.2% | Feb 8, 2023 |
| Citigroup | Analyst unavailable | $34.31 | $29.14 | -75.6% | Dec 15, 2022 |
| Credit Suisse | Analyst unavailable | $35.98 | $27.56 | -74.4% | May 4, 2022 |
| Mizuho Securities | Analyst unavailable | $40.59 | $27.52 | -71.1% | May 4, 2022 |
| Fermium Research | Frank Mitsch | $32.64 | $28.7 | -76.8% | Apr 18, 2022 |
| Deutsche Bank | David Begleiter | $37.66 | $32.11 | -73.2% | Mar 21, 2022 |
| Morgan Stanley | Vincent Andrews | $38.91 | $34.59 | -72.3% | Jan 11, 2022 |
| UBS | John Roberts CFA | $42.68 | $31.33 | -69.6% | Dec 20, 2021 |
| Vertical Research | Jeffrey Sprague | $39.75 | $32.15 | -71.7% | Nov 2, 2021 |
| J.P. Morgan | Stephen Tusa | $35.56 | $29.12 | -74.7% | Oct 4, 2021 |
| Argus Research | Bill Selesky | $38.91 | $34.28 | -72.3% | May 14, 2021 |
| Goldman Sachs | Robert Koort | $42.68 | $34.11 | -69.6% | May 11, 2021 |
Track every rating change on DD the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.